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Portable Near Infrared spectroscopy (NIRs) coupled to chemometrics was investigated
for the first time as a novel entirely on-site approach for occupational exposure monitoring
in pharmaceutical field. Due to a significant increase in the number of patients receiving
chemotherapy, the development of reliable, fast, and on-site analytical methods to
assess the occupational exposure of workers in the manufacture of pharmaceutical
products, has become more and more required. In this work, a fast, accurate, and
sensitive detection of hydroxyurea, a cytotoxic antineoplastic agent commonly used
in chemotherapy, was developed. Occupational exposure to antineoplastic agents
was evaluated by collecting hydroxyurea on a membrane filter during routine drug
manufacturing process. Spectra were acquired in the NIR region in reflectance mode
by the means of a miniaturized NIR spectrometer coupled with chemometrics. This
MicroNIR instrument is a very ultra-compact portable device with a particular geometry
and optical resolution designed in such a manner that the reduction in size does
not compromise the performances of the spectrometer. The developed method could
detect up to 50 ng of hydroxyurea directly measured on the sampling filter membrane,
irrespective of complexity and variability of the matrix; thus extending the applicability of
miniaturized NIR instruments in pharmaceutical and biomedical analysis.
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INTRODUCTION
Hydroxyurea (HU) or hydroxycarbamide, is a non-alkylating hydroxylated urea analog mainly
recognized as antineoplastic and antiviral agent (Spivak and Hasselbalch, 2011). The cytotoxic and
genotoxic potential efficacy of hydroxyurea makes this molecule one of the most performing agent
commonly used in chemotherapy (Spivak and Hasselbalch, 2011; Karsy et al., 2016; Liew et al.,
2016). In addition, HU is usually involved in the treatment of Sickle Cell Disease (SCD) (Davies
and Gilmore, 2003; Heeney andWare, 2008; Italia et al., 2009; Flanagana et al., 2010; Candrilli et al.,
2011), psoriasis (Yarbro and Leavell, 1969), Philadelphia-chromosome negative myeloproliferative
syndromes (MPs) (Yarbro and Leavell, 1969), some types of solid cancers (Karsy et al., 2016), and
in the therapy of HIV infection (Lori et al., 1994).
An important issue when dealing with HU is related to its harmful potential (Millicovsky et al.,
1981;Woo et al., 2005) especially in prolonged exposure conditions (Elchuri et al., 2015; Broto et al.,
2017), as it inhibits class I ribonucleotide reductase, leading to replication fork stalling (Quattrone
et al., 2013; Liew et al., 2016).Workers involved in themanufacture of drugs, may be exposed to HU
during manufacturing, transport, and distribution. In addition, as the number of patients receiving
chemotherapy has considerably increased, there is a growing concern about the development of
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reliable, fast and accurate methods to assess the occupational
exposure of workers during drug manufacturing process.
A number of analytical methods have been developed
to quantify hydroxyurea in biological fluids, including
spectrophotometric measurements by colorimetric techniques
(Milks and Janes, 1956; Davidson and Winter, 1963; Bolton
et al., 1965; Sivakumar et al., 2013; Legranda et al., 2017),
electroanalytical determination (Naik et al., 2015), Nuclear
Magnetic Resonance (NMR) (Main et al., 1987; Sorg et al.,
2005; De Marco et al., 2011), High Performance Liquid
Chromatography (HPLC) (Pujari et al., 1997; Iyamu et al., 1998;
Manouilov et al., 1998), Gas Chromatography coupled to Mass
Spectrometry (GC-MS) (James et al., 2006; Kettani et al., 2009;
Garg et al., 2015), and Liquid chromatography—tandem mass
spectrometry (LC-MS/MS) (Dalton et al., 2005; Usawanuwat
et al., 2014; Marahatta et al., 2016; Hai et al., 2017). Despite
the copious literature for HU detection, the assay of HU may
be cumbersome due to its molecular dimension, reactivity and
ability to chemical and enzymatic degradation (Iyamu et al.,
1998; Marahatta and Ware, 2017).
The National Institute for Occupational and Safety Health
(NIOSH) (Naumann et al., 1996) has proposed the exposure
control limits (ECL) for HU not exceeding 0.01 mg/m3,
as a consequence of the potential toxicity. Conventional
chromatographic techniques (Osytek et al., 2008) usually
require an accurate sample clean-up to extract HU from a
filter membrane and eliminate matrix interferences. All these
procedures may be critical in estimating a tiny amount of HU
and may lead to sample modification (Osytek et al., 2008).
To overcome these problems, spectroscopic techniques have
been largely proposed to give both qualitative and quantitative
information about complex samples (Zontova et al., 2016;
Materazzi et al., 2017a,b). In addition, multivariate statistical
analysis has already proved to be helpful in interpreting complex
spectral signals (Oliveri et al., 2011; Risoluti et al., 2016a,b, 2018;
Materazzi et al., 2017c).
In this work, Near Infrared Spesctroscpy is proposed as a
rapid and non-destructive technique to detect and quantify HU
on a glass fiber filter in order to assess a novel procedure
for occupational exposure estimation. A very ultra-compact
portable instrument named MicroNIR (45-mm diameter, 42-
mm height and 60-g operating weight) entirely powered (5V)
and controlled via USB port of a portable computer, was used
to acquire spectra; and chemometrics tools were considered
to perform real-time estimation of HU. A key feature of our
portable MicroNIR/Chemometrics approach is mainly related
to the possibility of directly analyze samples without any pre-
treatment or extraction. In addition, the method is simple




Hydroxyurea reference standard was purchased as powder from
Sigma-Aldrich. Glass fiber filters with 2.5-cm diameter, 1-µm
pore size, and 790-µm thickness (Merk Millipore) were used as
membrane to collect HU. Sampling was performed by the means
of a Chronos sampling device (Zambelli Srl) operated at a flow
rate of 3.5 L/min for 15min, in order to mimic occupational
exposure (not exceeding 3.5 µg/filter). Reference materials were
prepared in a glove-box module consisting of a cube-shaped
glass box isolated from the ambient temperature and 40 µl of
HU solution in deionized water at different concentrations were
added to reproduce the potential amounts of HU on a filter (50,
3.5 ng, and 50 µg).
MicroNIR/Chemometrics Method
Spectra were collected by a portable, ultra-compact and low-
cost device MicroNIR spectrometer, developed and distributed
by Viavi Solutions (JDSU Corporation, Milpitas, USA). This
device operates in the spectral region 900–1,700 nm and
consists of a linear variable filter (LVF) as dispersing element
directly connected to a 128-pixel linear indium gallium arsenide
(InGaAs) array detector and two tungsten light bulbs as radiation
source.
In the MicroNIR, measuring the optimum focal point of the
illumination source from the spectrometer’s window to a sample
is achieved by the means of a special collar. As a result, this
particular geometry permits to achieve comparable outcomes as
the reduction in size does not compromise the performances
of the spectrometer. The instrument control was performed by
the MicroNIR Pro software (JDSU Corporation, Milpitas, USA)
and chemometric tools such as Principal Component Analysis
(PCA) and Partial Least Square (PLS) algorithms were used
as unsupervised technique and calibration models by V-JDSU
Unscrambler Lite (Camo software AS, Oslo, Norway).
Spectra were collected at a nominal spectral resolution of
6.25 nm in the reflectance mode. Spectralon was used as NIR
reflectance standard (blank), with a 99% diffuse reflectance, while
a dark reference was obtained from a fixed place in the room. The
acquisitions were performed with an integration time of 10ms,
resulting in a total measurement time of 2.5 s for each sample.
As recommended for spectroscopic data (Rinnan et al.,
2009), mathematical pre-treatments were considered for
chemometric evaluation such as scatter-correction methods
[Standard Normal Variate transform (SNV) (Barnes et al., 1989),
Multiplicative Scatter Correction (MSC) (Geladi et al., 1985), and
Mean Centering (Wold and Sjöström, 1977)], Savitzky-Golay
(SG) polynomial derivative filters (Savitzky-Golay, 1964) as
spectral derivation techniques. Among these pre-treatments,
the combination of second derivative algorithm followed by
Mean Centering was selected because it provided the best
outcomes in terms of Root Mean-Squared Error of Calibration
(RMSEC), Root Mean-Squared Error of Prediction (RMSEP),
and coefficient of determination (R2) (Miller and Miller, 2000;
Mark and Workman, 2007).
Figures of merits were used to estimate model performances.
In particular, Residual Predictive Deviation (RPD) was used
to evaluate correction forecasting model and calculated as
the standard deviation (SD)/RMSEP. In general, the model is
considered stable when RPD ≥3 or not satisfactory when RPD
<2. In this work, the precision of the method was determined
on nine different samples with concentrations regularly
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FIGURE 1 | Sampling procedure of HU on a filter by acquiring nine spectra for each membrane (A) in a preserved glove box (B).
distributed along the linear range, using nine replicates in the
same day.
Sensitivity (SEN) represents the fraction of the analytical
signal responsible for an increase in the concentration of HU
and was calculated as follows: SEN = 1/b, where b is the
vector of regression coefficients with A latent variables. The
minimum detectable concentration (MDC) is defined as the
lowest concentration that can be reliably measured according to
ISO 11843-2:2000 recommendations1.
Experimental Design
Calibration and validation models were developed using the
dataset from 297 samples. The data set was divided into two
groups, the calibration set (216 samples) and validation set
(81 samples). In order to provide a sample selection for the
calibration and validation set as representative as possible and to
ensure uniformity of dataset, the X and Y distances were taken
into account simultaneously, by applying the Kennard–Stone
(KS) uniform sampling algorithm. The calibration set consisted
of a series of reference samples including blanks (filters without
HU) and fortified blanks with increasing amounts of HU (50, 3.5
ng, and 50 µg).
A comprehensive sampling procedure was scheduled as
follows: samples were collected in a preserved glove box and nine
spectra were acquired in reflectance mode for each membrane, as
shown in Figure 1. A total of nine filters were used to optimize
the model of prediction for HU exposure. Six independent
1ISO 11843-2:2000. Capability of Detection, International Standards Organization.
Geneva.
batches were prepared for calibration; while validation was
performed on the same type of samples as the calibration set, but
fully independent batches, using three series of filters.
GC-MS Method
GC-MS analysis was done on a Perkin Elmer system (Waltham,
MA) using a HP-5MS (30m × 0.25mm × 0.25mm) as
capillary separation column. Electron impact (EI) ionization was
employed at a voltage of 70 eV. The carrier gas was helium
delivered at a constant flow of 1 mL/min. The oven temperature
program was initially set at 150◦C for 1min, ramped to 140◦C at
12◦C/min and maintained for 1min, and then ramped to 270◦C
at 35◦C/min for 2.5min. The temperatures for the inlet, interface,
ion source and quadrupole were set at 270, 250, 230, and 150◦C,
respectively. Mass spectral data was collected in the scan mode
from m/z 44 to 400; in the SIM mode, fragments at 277 and
292 m/z were monitored for quantification and confirmation,
respectively.
RESULTS
To develop a novel analytical method to monitor occupational
exposure to cancerogenic agents by evaluating the amount of
HU on a filter, multivariate statistical analysis was performed
for optimal selection of the experimental procedure. As a
consequence, a number of variables were considered in order
to ensure a correct and representative sampling procedure: (a)
membrane type and sampling side; (b) sampling procedure
to reproduce HU exposure in terms of volume to be
added on a filter; (c) spectra acquisition. Preliminarily,
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all the acquired MicroNIR data corresponding to different
experimental conditions were pre-treated and processed by a
simple exploratory tool such as PCA. After that, a prediction
model of HU based on Partial Least Square Regression (PLSR)
was entirely developed and validated.
Sampling Procedure Optimization
To make the method representative, the first investigated issue
consisted of reference material preparation. Two different ways
of HU deposition on a filter were investigated: (i) calibration
on different filters i.e., four different filters (one blank and three
fortified blanks) were considered; and (ii) calibration on a single
filter i.e., only one filter was used and progressively fortified with
increasing amounts of HU. In this case, spectra of blank and
fortified samples were acquired prior to each deposition by the
portableMicroNIR. In the first case, samples were prepared using
40µl of aqueous solution of HUon each filter; while in the second
case, a volume of 15 µl was used for each deposition.
FIGURE 2 | Scores plot of the Principal Component Analysis performed on the dataset related to calibration on different filters (A) and calibration on a single filter (B).
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All the acquired spectra were pre-treated and analyzed
simultaneously by PCA. As displayed in Figure 2, each point
represents an average of the nine respective spectra of a filter
and colors were used to highlight the quantity of HU. The
interpretation of the scores plot provides preliminary important
information with respect to HU deposition and correlation to its
different amounts on a filter.
A good correlation could be observed for samples of the
same class (blank and fortified blanks) as there was no data
dispersion, suggesting a correct repeatability of the method. This
observation is very interesting because it is possible to clearly
discriminate HU quantity on the membrane of a filter. For any
deposition way, hence, the method would be suitable in practice
where occupational exposure of workers may be monitored by
a personal sampling system collecting a real blank (prior to HU
handling) to be fortified and directly analyzed.
In addition, as shown in Figure 2, in both cases moving along
PC1 (97 and 89% of explained variance) all the analyzed samples
could be well grouped according to HU amount. It further
confirms the ability of the approach MicroNIR/Chemometrics
in monitoring occupational exposure to HU according to its
amount collected on a filter.
A deeper investigation of the acquired spectra was performed
by comparing the two series of samples (four- and one-filter
calibration) in a single dataset. Figure 3 displays PCA data
showing that the same samples can be divided into two main
groups according to PC2: four- and one-filter calibration. As
a result of the PCA data, the different locations of samples in
the plot indicate the contribution of HU deposition way on the
spectroscopic signal.
Such a result is not surprising when a reflectance acquisition
mode is involved, because the surface of the filter membrane
may have some influence on the spectral response as a function
of the volume added. Despite the different behaviors, samples
could be clearly differentiated according to PC1 (91% of
explained variance) and the preliminary outcomes suggested
the possibility to further investigate the repeatability of the
method.
With the aim of extending this procedure to real samples,
nine different filters were prepared and subsequently fortified
with different amounts of HU so as to increase the number of
investigated samples and evaluate whether the method would
be batch-dependent. As shown in Figure 4, all the samples
of the same class (displayed in different colors), could be
well grouped and located in the plot according to PC1. In
addition, no dispersion of data was observed thus indicating
the effectiveness of the optimized HU deposition on a filter.
On the basis of preliminary interesting results, a prediction
model of HU on a single filter membrane was successfully
validated.
PLS Model of Prediction
In order to obtain the best results of calibration, the
effect of a number of pre-treatments was evaluated i.e., the
combination of spectral pre-treatments and wavelength range
selection.
FIGURE 3 | Scores plot of the Principal Component Analysis performed on the datasets from the two different ways of HU deposition on a filter.
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FIGURE 4 | Scores plot of the Principal Component Analysis performed on the entire dataset of collected samples.
TABLE 1 | Figures of merit of HU calculated with different spectral pre-treatments
in calibration and prediction steps.
Pre-treatment Calibration Prediction
R2 RMSEC R2 RMSEP RPD
SNV + Mean centering 0.9985 1.98 0.9973 2.14 1.9
MSC + Mean centering 0.9889 2.02 0.9817 1.26 1.5
1st derivative + Mean
centering
0.9999 0.61 0.9998 1.02 2.1
2nd derivative + Mean
centering
1.0000 0.09 1.0000 0.12 5.4
Calibration and validation sets were pre-processed using
Standard Normal Variate (SNV) scaling (Barnes et al., 1989),
MSC (Geladi et al., 1985), and Mean Centering (Wold and
Sjöström, 1977), Savitzky-Golay (SG) polynomial derivative
filters (Savitzky-Golay, 1964) and a combination of these pre-
treatments.
For evaluation of model performances, comparison was made
for different spectral pre-treatments to identify the most effective
one in terms of prediction error using the Predicted Residual
Error Sum of Squares (PRESS) to represent the sum of squares
of the prediction error and the coefficient of determination (R2).
Usually, the smaller the PRESS value is, the better the model’s
predictive ability is. R2 provides the percentage variation in y
explained by x-variables and is largely used to evaluate the fitting
performance. Satisfactory results (R2 and RMSEC) were obtained
for the calibration of HU as shown in Table 1.
Good model agreement is confirmed in the validation step
(R2 > 0.9817 and RMSEP < 2.14 for all the optimized models).
As far as the data are concerned, the best performance can be
achieved by using second derivative pre-treatment followed by
mean centering (4 latent variables) as it provides the lowest RMSE
and highest R2 values. Furthermore, the effect of the variable
spectral selection within the calibration block was evaluated to
improve the model’s ability to predict HU. As illustrated in
Figure 5, the first principal component loadings accounted for
more than 87% of the total variance.
Validation results of the most performing model (second
derivative pre-treatment followed by mean centering) after
variable selection in the range 1,540–1,600 nm are reported in
Table 2, showing that the optimized model could quantify HU
on a glass fiber filter with limit of detection of 50 ng/filter.
This finding points out that an adequate PLS regression model
can help quantify HU directly from MicroNIR measurements
without any prior sample preparation.
Evaluation of Prediction Ability
The validated model was consequently used to process 30 filters
collected during routine HU handling. In order to evaluate
the prediction ability of the model, all the samples were
simultaneously analyzed by the reference method (GC-MS)
and MicroNIR/Chemometrics approach. Data obtained from
the MicroNIR approach (Table 3) show that the PLS model
permitted to achieve the best prediction precision with RMSEP of
0.12 and RPD of 6.1, which ensured the accuracy and robustness
of the model.
In addition, the chromatographic analysis detectedHU in only
19 of the 30 samples as the Limit of Detection (LOD) and Limit
of Quantification (LOQ) of this method were 0.7 and 2.5 µg,
respectively. When the amount of HU was chromatographically
found to be lower than the LOQ of the method, LOD
was used to compare with the predicted values obtained by
MicroNIR/Chemometrics approach. The results showed a R2
of 0.99 and acceptable values of bias at 95% confidence (see
Table 3).
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FIGURE 5 | First principal component loading variation and variable spectral selection.











Mean ± SD (µg) 23.8 ± 0.65
*Latent variables. **Minimum detection concentration.







Mean ± SD (µg) 3.6 ± 0.73
MicroNIR computed values were found to be significantly
lower than corresponding GC ones as the LOD of the MicroNIR
method is 50 ng, meaning that the MicroNIR/Chemometrics can
be a promising approach for occupational exposure monitoring
at HU low levels.
CONCLUSIONS
An ultra-compact portable device (MicroNIR) was applied to
assess a novel way for HU occupational exposure monitoring.
A comprehensive sampling procedure was pointed out.
Chemometric evaluation of spectra collected by a miniaturized
device operated in the Near Infrared region, was optimized and
entirely validated by PLS regression. The proposed method has
the advantage of simplicity and avoiding sample pre-treatment,
thus limiting even the analyst’s HU exposure. Moreover, this
approach may be considered as the optimal technology to
determine cancerogenic agents or other dangerous molecules
in a single-touch analysis as it is entirely portable and non-
destructive. The achieved results highlight the extremely high
potential of MicroNIRs to detect the HU with lower detection
limits with respect to reference methods. To the best of the
authors’ knowledge, this approach would be the first ever
proposed for the on-site detection of HU. It requires no sample
preparation, is non-destructive and easy to perform (no highly-
skilled personnel required), allowing a rapid evaluation of theHU
occupational exposure.
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